 | |
- close
- close
|
MarketWatch
Sep 15
Comment
Novartis, the Basel health-care giant, said on Tuesday that results from Phase III trials showed that QAB149, generically indacaterol, in testing as a once-daily bronchodilator for chronic obstructive pulmonary disease, "significantly improves...
PR Newswire
Aug 28
Comment
TOSU, Saga, Japan and MIAMI, Aug. 27 /PRNewswire-FirstCall/ -- Hisamitsu Pharmaceutical Co., Inc. (TSE: 4530) and Hisamitsu U.S., Inc. today announced the completion of their acquisition of Noven Pharmaceuticals, Inc. pursuant to a short form merger
PR Newswire
Aug 27
Comment
TOSU, SAGA, Japan, Aug. 27 /PRNewswire/ -- Hisamitsu Pharmaceutical Co., Inc. (TSE: 4530) today announced the expiration of the subsequent offering period and completion of the tender offer for all outstanding shares of Noven Pharmaceuticals, Inc.
StreetInsider.com
Aug 18
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/S%26P+Announces+Update+to+US+Indices+Liquidity+Criteria%3B+SIGM+to+Replace+NOVN/4886863.html for the full story.
Marketwire
Jul 22
Comment
DALLAS, TX -- (Marketwire) -- 07/22/09 -- Kendall Law Group, led by a former federal judge and U.S. Attorney, announces a shareholder class action has been filed in Delaware Chancery Court on behalf of current investors of Noven Pharmaceuticals, Inc.
Finance Asia
Jul 15
Comment
Hisamitsu becomes the fourth Japanese pharmaceutical company to announce a US acquisition in the recent past, as it makes a tender offer for transdermal and women's health company Noven.
newratings.com
Jul 15
Comment
NEW YORK, July 15 (newratings.com) - Analysts at Caris & Company downgrade Noven Pharmaceuticals, Inc (ticker: NOVN) from "buy" to "neutral." The target price is set to $16.50. [more]
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
NOVN AT A GLANCE
References
| ||||||
|
|
